1261432-00-1 - Names and Identifiers
1261432-00-1 - Physico-chemical Properties
Molecular Formula | C22H18N4OS
|
Molar Mass | 390.484 |
Storage Condition | -20°C |
1261432-00-1 - Introduction
Axitinib is a cancer treatment that belongs to a class of drugs called tyrosine kinase inhibitors. Axitinib-13C-d3 refers to impurities present in the axitinib molecule. Axitinib -13C-d3 is an isotopic label that replaces some hydrogen atoms with carbon 13 and deuterium (protons with deuterium).
The properties and uses of axitinib -13C-d3 are similar to axitinib. It is mainly used in pharmacokinetic studies, drug interaction analysis and bioavailability studies. It can be used as an internal standard substance for drug analysis and detection for quantitative analysis.
axitinib -13C-d3 is mainly synthesized by synthetic chemical methods. This process involves labeling the axitinib molecule with carbon -13 and deuterium stable isotopes to obtain the desired chemical.
Regarding safety information, there is relatively limited information on the safety and toxicity of axitinib -13C-d3. However, compared to axitinib, its toxicity may be lower due to its small magnitude of use as a marker. Care and proper handling are still required to ensure proper personal protection and safe laboratory operation. Before using axitinib -13C-d3, it is recommended to consult the drug or chemical supplier for detailed safety information and operational guidelines.
Last Update:2024-04-09 21:04:16